ANGO (STOCKS)
AngioDynamics, Inc.
$11.030000
-0.340000 (-2.99%)
Prev close: $11.370000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- James Christopher Clemmer
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $455.45M
- Employees
- 675
- P/E (TTM)
- -16.38
- P/B (TTM)
- 2.68
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q2)
|
$0.00 | $-0.10 | +0.1020 | +100.00% |
|
Sep 2025 (Q1)
|
$-0.10 | $-0.12 | +0.0199 | +16.60% |
|
Jun 2025 (Q4)
|
$-0.03 | $-0.12 | +0.0924 | +75.49% |
|
Mar 2025 (Q3)
|
$0.03 | $-0.13 | +0.1626 | +122.62% |
Financial Statements
| Revenues | $307.31M |
| Benefits Costs and Expenses | $335.02M |
| Cost Of Revenue | $139.59M |
| Costs And Expenses | $335.02M |
| Gross Profit | $167.72M |
| Operating Expenses | $200.26M |
| Depreciation and Amortization | $23.92M |
| Research and Development | $27.69M |
| Other Operating Expenses | $154.97M |
| Operating Income/Loss | -$32.54M |
| Income/Loss From Continuing Operations After Tax | -$27.71M |
| Income/Loss From Continuing Operations Before Tax | -$27.71M |
| Income Tax Expense/Benefit | -$2.00K |
| Income Tax Expense/Benefit, Deferred | -$464.00K |
| Net Income/Loss | -$27.71M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$27.71M |
| Net Income/Loss Available To Common Stockholders, Basic | -$27.71M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.67 |
| Diluted Earnings Per Share | -$0.67 |
| Basic Average Shares | 82,301,000 |
| Diluted Average Shares | 82,301,000 |
| Assets | $269.68M |
| Current Assets | $161.35M |
| Inventory | $65.57M |
| Other Current Assets | $95.78M |
| Noncurrent Assets | $108.33M |
| Fixed Assets | $30.53M |
| Intangible Assets | $66.73M |
| Other Non-current Assets | $11.07M |
| Liabilities | $93.35M |
| Current Liabilities | $71.96M |
| Accounts Payable | $35.39M |
| Wages | $14.34M |
| Other Current Liabilities | $22.24M |
| Noncurrent Liabilities | $21.39M |
| Equity | $176.33M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $176.33M |
| Liabilities And Equity | $269.68M |
| Net Cash Flow From Operating Activities | -$5.60M |
| Net Cash Flow From Operating Activities, Continuing | -$5.60M |
| Net Cash Flow From Investing Activities | -$8.98M |
| Net Cash Flow From Investing Activities, Continuing | -$8.98M |
| Net Cash Flow From Financing Activities | $1.43M |
| Net Cash Flow From Financing Activities, Continuing | $1.43M |
| Exchange Gains/Losses | $706.00K |
| Net Cash Flow | -$12.45M |
| Net Cash Flow, Continuing | -$13.16M |
| Comprehensive Income/Loss | -$22.96M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$22.96M |
| Other Comprehensive Income/Loss | $15.44M |